Cogstate supports hundreds of clinical trials in all phases. Our solutions are validated in 600+ peer-reviewed publications.
Reducing risk in clinical trials with more reliable results.
Combining these essentials, study teams increase their chances for successful trials and can make earlier and more informed decisions about their therapeutic drug candidates.
Cogstate solutions guide thousands of researchers across many indications and all phases of development. With our sensitive, rapid, and reliable computerized digital cognitive assessments, proven rater training and data quality programs, and study design insights from leading scientists, we help clinical trial partners optimize outcomes.
Our team of scientific and operational experts have supported study outcomes in 60+ indications across neurology, rare diseases, mood disorders, oncology, movement disorders, and infectious disease. Learn more about our unique capabilities in a selection of key focus areas:
Having partnered with sponsors of all shapes and sizes, we offer study teams extensive hands-on experience across indications, study sizes, and operational designs. We bring together neurocognitive expertise with the data and technology to simplify brain health assessments and improve clinical trial decision-making.